Prospects for ferroptosis therapies in cancer

Jessalyn M Ubellacker1, Scott J Dixon2

  • 1Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health, Boston, MA, USA. jubellacker@hsph.harvard.edu.

Nature Cancer
|August 18, 2025
PubMed

Insights

Ferroptosis, a cell death pathway, shows promise for cancer treatment. However, translating this knowledge into clinical therapies faces significant challenges that need to be addressed.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Oncology

Background:

  • Ferroptosis is a distinct form of regulated cell death driven by lipid peroxidation.
  • This cell death pathway has been extensively studied in cancer cells for over a decade.
  • There is considerable interest in targeting ferroptosis for cancer therapy.

Purpose of the Study:

  • To review the current understanding of ferroptosis.
  • To highlight the gap between ferroptosis research and clinical applications in cancer therapy.
  • To discuss challenges hindering the translation of ferroptosis-inducing therapies into clinical trials.

Main Methods:

  • Literature review of ferroptosis mechanisms and cancer therapy research.
  • Analysis of challenges in translating preclinical findings to clinical settings.
  • Discussion of potential strategies to overcome therapeutic hurdles.

Main Results:

  • Ferroptosis is a well-characterized cell death mechanism with therapeutic potential.
  • Despite extensive research, no ferroptosis-inducing therapies have reached clinical trials.
  • Several challenges impede the clinical translation of ferroptosis-based cancer treatments.

Conclusions:

  • A significant gap exists between the scientific understanding of ferroptosis and its clinical application.
  • Overcoming challenges in ferroptosis induction and delivery is crucial for developing effective cancer therapies.
  • Further research and development are needed to bring ferroptosis-targeting treatments to cancer patients.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.8K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K